Certolizumab Pegol for Treatment of Plaque Psoriasis: Pooled Three-Year Efficacy Outcomes from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2). J of Skin 2019, 3, S37. https://doi.org/10.25251/skin.3.supp.37.